Strong first half for Zotefoams
Foam products maker, Zotefoams, reported a strong first half with profits and revenues up towards double digits.
Foam products maker, Zotefoams, reported a strong first half with profits and revenues up towards double digits.
Profit before tax rose by 9.5% to £3.59m on revenues that were up 9.9 % to £24.81m.
Earnings per share increased by 10.6% to 7.3p, while the company declared an increased dividend of 1.7p per share - a rise of 6.25%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company's Chairman, Nigel Howard, noted the turbulent macroeconomic conditions.
"During the first half of 2012, traditionally our more profitable trading period, we have delivered a strong performance in profit and operating cash generation," he said.
"We have made good underlying progress in the higher-growth parts of our business such as HPP and Azote foams in Asia, supported by a robust performance across the wider portfolio of our operations which will stand us in good stead for the future."
"With a strong forward order book, the company is trading in line with the board's expectations for the full year and we expect 2012 to be a year of further progress," he added.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published